Navigation Links
Study Results Show Investigational Drug, Prasugrel, Cuts Risk of Stent-Related Clots by More than Half Versus Clopidogrel
Date:3/29/2008

cent vs. 11.1 percent, p=0.019). Fatal stent thrombosis occurred in 18 (0.28 percent) patients treated with prasugrel and 29 (0.46 percent) patients treated with clopidogrel (p=0.10). Of note, of the 210 patients with stent thrombosis, 89 percent either died or had a myocardial infarction associated with the event.

The rate of major bleeding was higher in all patients receiving a stent treated with prasugrel vs. clopidogrel (2.4 percent vs. 1.9 percent, p=0.06). Major bleeding in both DES and BMS prasugrel-treated groups when compared to clopidogrel-treated patients was 3 percent vs. 2 percent (p=0.34 DES) and 2 percent vs. 2 percent (p=0.09 BMS).

In addition to a reduction in the primary endpoint (CV death, non-fatal heart attack, or non-fatal stroke), a significantly lower rate of the composite endpoint of cardiovascular death, heart attack or urgent target vessel revascularization (UTVR) was observed with prasugrel vs. clopidogrel for both bare metal stents (10 percent vs. 12 percent, p=0.009) and for drug- eluting stents (9 percent vs. 11 percent, p=0.004). A significant reduction was also seen in heart attack alone (8 percent vs. 10 percent, p=0.003, BMS and 7 percent vs. 9 percent, p=.006, DES). In DES-implanted patients, regardless of those receiving only sirolimus-eluting or paclitaxel-eluting stents, there was a similar magnitude of event reduction with prasugrel compared to clopidogrel.

For the entire cohort, sub-acute stent thrombosis (24 hours to 30 days) was 0.36 percent in prasugrel-treated patients vs. 1.19 percent in clopidogrel-treated patients (p<0.0001). DES-implanted patients had lower rates of stent thrombosis compared to BMS-implanted patients, and prasugrel was shown to significantly reduce stent thrombosis in DES-implanted patients within the first three days compared to clopidogrel (0.14 percent vs. 0.63 percent, p=0.003) as well as for thromboses that occurred >30 days following the DES implantation (0.42 percent vs. 0.
'/>"/>

SOURCE Eli Lilly and Company
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Trubion Initiates Phase 1/2 Study of TRU-016 in CLL, Announces Next-Generation Product Candidate for RA and Provides Product Pipeline Update
2. St. Jude Study Offers New Hope for Children With Kidney Tumors Deemed Inoperable
3. Sangart Completes Enrollment in Phase III Study of Its Novel Blood Substitute Hemospan
4. Sangamo BioSciences and Sigma-Aldrich Announce Publication of Study Demonstrating Zinc Finger Technology for Rapid Generation of Knock-Out Cell Lines
5. International ACTEMRA Rheumatoid Arthritis Study Highlighted in The Lancet
6. IDM Pharma Announces Availability of Mifamurtide (L-MTP-PE) Through Compassionate Access Study
7. PLC Systems Receives FDA Approval to Commence Pivotal Study Of RenalGuard(TM) In the U.S.
8. Alexion Completes Enrollment in AEGIS Registration Study of Soliris(R) (eculizumab) in Patients with PNH in Japan
9. New Study Reports That Physical Therapy Treatment Resolves Symptoms of Urinary Incontinence in Women
10. Emisphere Announces Second Study Demonstrating Dramatic Increases in Absorption of Oral B12 Using eligen(R) Technology at Lower Doses
11. Recent Data Study Suggests Cortisol Could Help Alleviate Suffering for Those With Chronic Fatigue Syndrome and Fibromyalgia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2015)... Feb. 26, 2015  Mobility Ventures LLC, an AM ... Bank of America (NYSE: BAC ) that ... financing of the revolutionary MV-1 - - the world,s ... ground up to provide safe and comfortable transportation for ... their loan to purchase a new MV-1 vehicle at ...
(Date:2/26/2015)... , Feb. 26, 2015 Legislation passed today ... pharmacy provision to help prevent inappropriate prescriptions in Medicare ... Protecting the Integrity of Medicare Act (PIMA) of 2014 ... Kevin Brady (R-TX) and Ranking Member Jim ... drug abuse epidemic and implement the right policies, said ...
(Date:2/26/2015)... 26, 2015 LifeScienceIndustryResearch.com adds ... -In- Class Innovations and Cost Optimization Plays Major ... Pharmaceutical Companies research report to the pharmaceuticals intelligence ... this Global Pharma US & EU Outlook 2015 ... divestment of non-core assets result in healthy cash ...
Breaking Medicine Technology:Mobility Ventures and Bank of America Announce New Agreement to Simplify Retail Consumer Financing for MV-1 Universally Accessible Vehicle 2Mobility Ventures and Bank of America Announce New Agreement to Simplify Retail Consumer Financing for MV-1 Universally Accessible Vehicle 3PCMA Statement on the 'Protecting the Integrity of Medicare Act' 2Global Pharma U.S. and EU Outlook 2015 Market Research Report 2Global Pharma U.S. and EU Outlook 2015 Market Research Report 3Global Pharma U.S. and EU Outlook 2015 Market Research Report 4
... 11 Pharmasset, Inc.,(Nasdaq: VRUS ), a clinical ... to treat viral,infections, reported financial results for the fiscal year ... million in cash and cash,equivalents and short term investments. , ... Highlights , Clevudine , ...
... Inc. (OTC Bulletin Board: CVBT) announced today that two additional ... its ACORD Phase II clinical trial for the treatment of ... Foundation in Minneapolis MN, and Princeton Baptist Medical Center in ... Mercy Hospital Fairfield (Ohio) and The Christ Hospital in ...
Cached Medicine Technology:Pharmasset Reports Fiscal Year End 2008 Financial Results 2Pharmasset Reports Fiscal Year End 2008 Financial Results 3Pharmasset Reports Fiscal Year End 2008 Financial Results 4Pharmasset Reports Fiscal Year End 2008 Financial Results 5Pharmasset Reports Fiscal Year End 2008 Financial Results 6Pharmasset Reports Fiscal Year End 2008 Financial Results 7Pharmasset Reports Fiscal Year End 2008 Financial Results 8Pharmasset Reports Fiscal Year End 2008 Financial Results 9CVBT Opens Two Additional Sites for Patient Enrollment for Phase II Heart Trial 2
(Date:2/27/2015)... WI (PRWEB) February 27, 2015 ... - The program, which is free and open to ... month, 8:15-9:30 am, at the Janesville Mall Food Court, ... breakfast, health screenings, door prize drawings, and an educational ... sign up for membership in Stride for Health. , ...
(Date:2/27/2015)... 27, 2015 One of the biggest ... aftercare instructions. These tips help ensure you receive ... make. , “Investing time and effort in your recovery ... the right plastic surgeon,” says Dr. Kevin Sadati. , ... the highest and longest lasting results following a facelift ...
(Date:2/26/2015)... (PRWEB) February 27, 2015 UAE Medical Insurance ... Ward to the position of Corporate Sales Director . Based ... the health insurance industry that he plans to leverage to ... Mr. Ward joined the health insurance industry in 1995, working ... to help grow Lifecare International - an agent of BUPA ...
(Date:2/26/2015)... (PRWEB) February 27, 2015 iTanSmart ... take the guesswork out of sun tanning by alerting the ... burned. iTanSmart also educates the user about UVB rays, sun ... uses five factors: UV index, time of day, skin type, ... time can be spent in the sun before getting burned. ...
(Date:2/26/2015)... 2015 February 2015 – A strong ... start-up company's most valuable assets. A weak (or poorly ... liabilities. All this is particularly true for developers in ... often occurs. According to Frank Becking , IP ... portfolio must be managed actively with value-driven goals in ...
Breaking Medicine News(10 mins):Health News:Gallery of Cosmetic Surgery Announces Tips for Protecting Your Plastic Surgery Investment 2Health News:UAE Medical Insurance Hires New Head of Corporate Sales and Retention 2Health News:UV Technologies Announces Development of iTanSmart Sun Tan App for Android Smartphones Helps Prevent Sunburns 2Health News:IP Priorities: Five Tips for Medical Device Entrepreneurs 2Health News:IP Priorities: Five Tips for Medical Device Entrepreneurs 3
... Dr. Paul Weinberger wants to make thyroid cancer diagnosis ... About 30 percent of women have a thyroid growth in ... said Weinberger, otolaryngologist at Georgia Health Sciences University. In about ... on the shape of biopsied thyroid cells. It,s ...
... needs to be considered when determining the potential ... disease and cancer. According to a new study ... use of low-dose aspirin increases the risk for ... with accompanying use of cardiovascular disease-preventing therapies, such ...
... new analysis has found that women who develop certain hereditary ... previous generation. Published early online in CANCER , a ... to the importance of tracking younger ages of cancer diagnosis ... Women who have mutations in the BRCA genes ...
... SATURDAY, Sept. 10 (HealthDay News) -- It,s important for parents ... children to do their homework, a new study suggests. ... homework improves if parents take a positive, supportive attitude and ... assignment or getting a higher grade. The study of ...
... HealthDay Reporter , FRIDAY, Sept. 9 (HealthDay News) ... that osteoporosis drugs such as Fosamax, Actonel, Boniva and ... patient should take a drug before potential health risks ... are taken to prevent fractures related to postmenopausal osteoporosis. ...
... Fusarium , a group of fungi that includes devastating ... travel through the air. Researchers now believe that ... a better understanding about crop security, disease spread, and ... towards a new aerobiological modeling technique, one they think ...
Cached Medicine News:Health News:Proteins could help women avoid thyroid surgery 2Health News:Even low-dose aspirin may increase risk of GI bleeding 2Health News:Women who inherit BRCA gene mutations develop cancer earlier than their ancestors 2Health News:Parents' Positive Attitude Can Help Kids Get Homework Done 2Health News:FDA Advisers Call for Revised Labels for Osteoporosis Drugs 2Health News:FDA Advisers Call for Revised Labels for Osteoporosis Drugs 3Health News:Microbes travel through the air; it would be good to know how and where 2Health News:Microbes travel through the air; it would be good to know how and where 3
... Smoothie is deliciously refreshing scrub ... the use of a gentle ... exfoliate the skin to restore ... irritation. This light chemical peel ...
... of Salicylic Acid Exfoliator 30% and ... be used by Physicians or Skin ... for intense skin peeling and exfoliation ... of skin correction. This kit works ...
... Fat Harvest, Wash & Transfer System is ... make fat transfer procedures simpler for the ... the need for an office-based technique. LipiVage™ ... is no longer a need to centrifuge, ...
... and Zyplast® injectable collagen implants have set ... facial lines, wrinkles and scars and in ... skins natural collagen, require minimal procedure time, ... one million people worldwide have been treated ...
Medicine Products: